Research progress of ovarian cancer

Ovarian cancer is the third most common gynecological malignancy after endometrial cancer and cervical cancer, and its mortality rate ranks first among gynecological malignancies. The treatment of ovarian cancer has always been the most difficult challenge faced by clinical work. Traditional radical surgery combined with adjuvant chemotherapy is still its basic treatment method. Neoadjuvant chemotherapy, radiotherapy, biological therapy, immunotherapy and molecular targeted therapy provide new options for the treatment of mid- and late-stage ovarian cancer.

Ovarian cancer is the third most common gynecological malignancy after endometrial cancer and cervical cancer, and its mortality rate ranks first among gynecological malignancies. Ovarian cancer is insidious, lacks early typical symptoms and mature early diagnosis methods. When clinical symptoms appear and patients pay attention to seek medical treatment, it is often in the late stage. When extensive abdominal metastasis occurs, radical surgery is difficult to perform.
Successful screening of ovarian cancer requires a highly sensitive and specific test. Serum CA-125 testing, pelvic ultrasound, abdominal and vaginal ultrasound examinations can be used for ovarian cancer screening. At the same time, CT and MR scans can be used to estimate the degree of tumor differentiation and location.